DHR vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
TSLA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TSLA |
| Current Price |
$221.12 |
$372.11 |
| Fair Value Estimate |
$286.52 |
$539.56 |
| Upside to Fair Value |
+29.6%
|
+45.0%
|
| Market Cap |
$155.4B |
$1,469.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
121.7x
|
| Price / Sales |
6.2x
|
14.2x
|
| Price / FCF |
28.5x
|
209.1x
|
| Revenue Growth YoY |
+5.5%
|
+25.5%
|
| Gross Margin |
58.5%
|
18.9%
|
| Operating Margin |
20.4%
|
4.2%
|
| Return on Equity |
7.7%
|
4.6%
|
| Dividend Yield |
0.65% |
0% |
| FCF Yield |
3.51%
|
0.48%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell …
Accumulation Zones
| Metric |
DHR |
TSLA |
| Zone Low |
$214.89 |
$404.67 |
| Zone High |
$243.54 |
$458.63 |
| In Buy Zone? |
Yes
|
Yes
|